Sign in

CIK 0001645469

  • Non-accelerated filer
  • Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320463781
Phone
+1 847-388-0349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise Director acquired 751 shares (option exercise)
  3. 4 Option exercise Director acquired 751 shares (option exercise)
  4. 4 Option exercise Director acquired 751 shares (option exercise)
  5. 4 Option exercise Director acquired 751 shares (option exercise)
  6. 4 Shares withheld for taxes Chief Scientific Officer gave up 471 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 423 shares (to pay taxes)
  8. 4 Option exercise Director acquired 751 shares (option exercise)
  9. 4 Option exercise Director acquired 751 shares (option exercise)
  10. 4 Option exercise Director acquired 751 shares (option exercise)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 1,155 shares (to pay taxes)
  12. 4 Option exercise Director acquired 751 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Option exercise Director acquired 752 shares (option exercise)
  16. 4 Option exercise Director acquired 752 shares (option exercise)
  17. 4 Option exercise Director acquired 752 shares (option exercise)
  18. 4 Option exercise Director acquired 752 shares (option exercise)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 823 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Scientific Officer gave up 942 shares (to pay taxes)

Page 9 of 13 · 247 filings